Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Amlodipine for peak identification

Amlodipine for peak identification is listed in the pharmaceutical impurity collection under CAS 111470-99-6. Its represented structure has formula C26H31ClN2O8S and a calculated molecular weight of 567.06 g/mol.

2D chemical structure

O O O H 2 N H N O O C l O S O O H

Chemical identity

Catalog name
Amlodipine for peak identification
Common name
Amlodipine for peak identification
Chemical name
benzenesulfonic acid;3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
CAS
111470-99-6
SMILES
CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl.O=S(=O)(O)c1ccccc1
InChI
InChI=1S/C20H25ClN2O5.C6H6O3S/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21;7-10(8,9)6-4-2-1-3-5-6/h5-8,17,23H,4,9-11,22H2,1-3H3;1-5H,(H,7,8,9)
InChIKey
ZPBWCRDSRKPIDG-UHFFFAOYSA-N
Associated API
amlodipine

Record ID: A3f911e7b9c42

Computed properties

C26H31ClN2O8S Molecular formula
567.06 g/molMolecular weight
566.149 DaMonoisotopic exact mass
154.25 ŲTopological polar surface area
3.1996 Calculated LogP (Wildman–Crippen)
141.8337 cm³/molMolar refractivity (Wildman–Crippen)
9 countHydrogen-bond acceptors
3 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. The SMILES contains 2 disconnected components. Calculations retain all represented components. 1 potential atom stereocenters have unspecified configuration.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 3 6 9 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C Cl H N O S 0 8 16 24 32 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight567.0690.22
Calculated LogP (Wildman–Crippen)3.199665.59
Topological polar surface area154.2589.95
Hydrogen-bond acceptors991.13
Hydrogen-bond donors381.39
Rotatable bonds (strict)986.25

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC26H31ClN2O8Sdimensionless
Molecular weight567.06g/mol
Monoisotopic exact mass566.149Da
Topological polar surface area154.25Ų
Calculated LogP (Wildman–Crippen)3.1996dimensionless
Molar refractivity (Wildman–Crippen)141.8337cm³/mol
Hydrogen-bond acceptors9count
Hydrogen-bond donors3count
Rotatable bonds (strict)9count
Heavy atoms38count
Heteroatoms12count
Rings3count
Aromatic rings2count
Aliphatic rings1count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles1count
Saturated heterocycles0count
Aromatic carbocycles2count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.3077fraction
Formal charge0e
Disconnected components2count
Isotopically specified atoms0count
Potential atom stereocenters1count
Unspecified atom stereocenters1count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area226.7038Ų
Valence electrons206count
Radical electrons0count
Bertz complexity1,293.3362index
Balaban J0index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Amlodipine for peak identification

Qualification and safety assessment of Amlodipine for peak identification

Explore toxicological qualification of Amlodipine for peak identification and ICH M7 mutagenic impurity assessment of Amlodipine for peak identification for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Amlodipine for peak identification and acceptable intake and limit justification for Amlodipine for peak identification. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Amlodipine for peak identification

Explore Altox services and software through the Altox Pharma-Hub.